Research Article
BibTex RIS Cite

Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy

Year 2025, Volume: 8 Issue: 2, 53 - 55, 31.08.2025

Giorgio Ciprandi Attilio Varricchio Ignazio La Mantia

https://doi.org/10.65396/ejra.1825453

Abstract

OBJECTIVE
Nasal topical therapy plays a pivotal role in the management of a wide range of upper airway conditions, including allergic rhinitis, chronic rhinosinusitis, and postoperative care in nasal surgeries. The aim is to report a post hoc analysis on a survey on topical nasal therapy that included an extended list of pharmacological and non-pharmacological products to manage several upper respiratory tract diseases.
METHODS
This survey involved a questionnaire distributed via a web platform that ensured anonymity. Fellows of ORL Italian societies participated in the survey. The panel of experts who developed the Delphi Consensus drafted the questionnaire.
RESULTS
One hundred eight ORLs participated in the survey. Most of them were from Southern Italy and islands (57.4%). The most common disease topically treated is chronic rhinosinusitis with nasal polyps (82.4%), followed by allergic rhinitis (78.3%), non-allergic rhinitis (76.7%), chronic rhinosinusitis without nasal polyps (76.5%), chronic adenoiditis (73.4%), and acute rhinosinusitis and adenoiditis (70% and 69.8%, respectively).
CONCLUSION
This survey demonstrated that a group of Italian ORLs use topical nasal therapy essentially for type 2-mediated and infectious/inflammatory diseases, prefer a pre-dosed nasal spray and irrigation, and prescribe mostly corticosteroids and saline solutions.

Keywords

Topical nasal therapy; nasal drops antihistamines otorhinolaryngologist; survey.

References

  • 1. Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review. Drug Deliv Transl Res. 2013;3(1):42–62.
  • 2. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CC, Schuller D, Spector SL, Tilles SA; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):1–84.
  • 3. Meltzer EO, et al. Intranasal corticosteroids: pharmacology and new formulations. Allergy Asthma Proc. 2019;40(1):2–12.
  • 4. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;(3):CD006394.
  • 5. Albu S. Use of topical antibiotics in chronic rhinosinusitis without polyps: an update. Am J Rhinol Allergy. 2014;28(2):157–163.
  • 6. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004 Jun;113(6):1122-1128.
  • 7. Kaiser HB. The role of antihistamines in the treatment of asthma. J Allergy Clin Immunol. 2000;105(2):622–626.
  • 8. Costantino HR, et al. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm. 2007;337(1–2):1–24.
  • 9. Lavigne F, et al. Comparative analysis of nasal delivery techniques for postoperative care: a randomized controlled trial. Int Forum Allergy Rhinol. 2020;10(9):1085–1092.
  • 10. Saraceni Neto P, et al. Topical use of tranexamic acid for epistaxis: a systematic review. Int Arch Otorhinolaryngol. 2020;24(3):e361–e368.
  • 11. Wise SK, Damask C, Greenhawt M, et al. A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023. J Allergy Clin Immunol Pract. 2023;11(3):773-796.
  • 12. Varricchio A, Brunese FP, La Mantia I, Ascione E, Ciprandi G. Choosing nasal devices: a dilemma in clinical practice. Acta Biomed 2023;94(1):e2023034.
  • 13. Varricchio A, Presutti L, La Mantia I, Ciprandi G. Inter-societal Delphi Consensus on the topical nasal treatments in Italy. Multidiscip Respir Med. 2024 Sep 4;19(1):991-996. 
  • 14. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol 2020;146(4):721-767.
  • 15. Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective. Drug Deliv Trans Res 2013;3(1):42-62
There are 15 citations in total.

Details

Primary Language English
Subjects Clinical Sciences (Other)
Journal Section Research Article
Authors

Giorgio Ciprandi This is me

Attilio Varricchio This is me

Ignazio La Mantia This is me

Submission Date April 30, 2025
Acceptance Date June 19, 2025
Publication Date August 31, 2025
Published in Issue Year 2025 Volume: 8 Issue: 2

Cite

APA Ciprandi, G., Varricchio, A., & La Mantia, I. (2025). Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. European Journal of Rhinology and Allergy, 8(2), 53-55. https://doi.org/10.65396/ejra.1825453
AMA 1.Ciprandi G, Varricchio A, La Mantia I. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy. 2025;8(2):53-55. doi:10.65396/ejra.1825453
Chicago Ciprandi, Giorgio, Attilio Varricchio, and Ignazio La Mantia. 2025. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy 8 (2): 53-55. https://doi.org/10.65396/ejra.1825453.
EndNote Ciprandi G, Varricchio A, La Mantia I (August 1, 2025) Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. European Journal of Rhinology and Allergy 8 2 53–55.
IEEE [1]G. Ciprandi, A. Varricchio, and I. La Mantia, “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”, Eur J Rhinol Allergy, vol. 8, no. 2, pp. 53–55, Aug. 2025, doi: 10.65396/ejra.1825453.
ISNAD Ciprandi, Giorgio - Varricchio, Attilio - La Mantia, Ignazio. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy 8/2 (August 1, 2025): 53-55. https://doi.org/10.65396/ejra.1825453.
JAMA 1.Ciprandi G, Varricchio A, La Mantia I. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy. 2025;8:53–55.
MLA Ciprandi, Giorgio, et al. “Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy”. European Journal of Rhinology and Allergy, vol. 8, no. 2, Aug. 2025, pp. 53-55, doi:10.65396/ejra.1825453.
Vancouver 1.Ciprandi G, Varricchio A, La Mantia I. Survey on the Attitude of Italian Otorhinolaryngologists Concerning the Topical Nasal Therapy. Eur J Rhinol Allergy [Internet]. 2025 Aug. 1;8(2):53-5. Available from: https://izlik.org/JA75LX48BF

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.